Sitagliptin, a dipeptidyl peptidase-IV inhibitor, attenuates retinal neurodegeneration in rd10 mice

被引：0
|
作者：
Kutsyr, O. [1 ]
Fernandez-Sanchez, L. [2 ]
Maneu, V. [2 ]
Lax, P. [1 ]
Ambrosio, A. F. [3 ]
Cuenca, N. [1 ]
机构：
[1] Univ Alicante, Physiol Genet & Microbiol, Alicante, Spain
[2] Univ Alicante, Opt Pharmacol & Anat, Alicante, Spain
[3] Univ Coimbra, Coimbra Inst Clin & Biomed Res, Fac Med, Coimbra, Portugal
来源：
ACTA OPHTHALMOLOGICA | 2018年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
S093
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [1] Dipeptidyl deptidase-IV inhibition by sitagliptin slows down retinal neurodegeneration in rd10 mice retinas
    Kutsyr, Oksana
    Arango-Gonzalez, Blanca
    Fernandez-Sanchez, Laura
    Maneu, Victoria
    Lax, Pedro
    Ambrosio, Antonio F.
    Ueffing, Marius
    Cuenca, Nicolas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [2] Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis
    Nishioka, Tatsuya
    Shinohara, Masayuki
    Tanimoto, Noriyasu
    Kumagai, Chizuru
    Hashimoto, Kozo
    DERMATOLOGY, 2012, 224 (01) : 20 - 21
  • [3] Drug eruption caused by sitagliptin, a dipeptidyl peptidase-IV inhibitor
    Tanaka, Keiko
    Ogawa, Youichi
    Shimada, Shinji
    JOURNAL OF DERMATOLOGY, 2012, 39 (08): : 726 - 728
  • [4] Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals
    Davis, Joseph A.
    Singh, Shuchita
    Sethi, Sachin
    Roy, Subhasis
    Mittra, Shivani
    Rayasam, Geetavani
    Bansal, Vinay
    Sattigeri, Jitendra
    Ray, Abhijit
    INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (04) : 229 - 233
  • [5] Decreased hepatic glucose production in obese rats by dipeptidyl peptidase-IV inhibitor sitagliptin
    Lu Ying-li
    Zhou De-quan
    Zhai Hua-ling
    Wu Hui
    Guo Zeng-kui
    CHINESE MEDICAL JOURNAL, 2012, 125 (10) : 1690 - 1694
  • [6] Evaluation of Dipeptidyl Peptidase-IV Inhibitor Use in the Inpatient Setting
    Petite, Sarah E.
    Hill, Maja C.
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (02) : 229 - 234
  • [7] Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob/ob male mice
    Onoyama, Takumi
    Koda, Masahiko
    Okamoto, Toshiaki
    Kishina, Manabu
    Matono, Tomomitsu
    Sugihara, Takaaki
    Murawaki, Yoshikazu
    MOLECULAR MEDICINE REPORTS, 2015, 12 (05) : 6895 - 6902
  • [8] Dose-proportionality of sitagliptin (MK-0431), an oral dipeptidyl peptidase-IV inhibitor, in healthy volunteers.
    Bergman, A
    Krishna, R
    Mistry, G
    Luo, W
    Liu, Q
    Stone, J
    Wang, A
    Zeng, W
    Chen, L
    Dilzer, S
    Lasseter, K
    Wagner, J
    Herman, G
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1090 - 1090
  • [9] Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats
    Lim, Soo
    Choi, Sung Hee
    Shin, Hayley
    Cho, Bong Jun
    Park, Ho Seon
    Ahn, Byung Yong
    Kang, Seon Mee
    Yoon, Ji Won
    Jang, Hak Chul
    Kim, Young-Bum
    Park, Kyong Soo
    PLOS ONE, 2012, 7 (04):
  • [10] Sitagliptin: A dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Miller, Shannon A.
    St. Onge, Erin L.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (7-8) : 1336 - 1343
12345